
| Disease | Risk of contracting | Risk of death |
|---|---|---|
| Hepatitis B | Negligible for under 5s | Negligible for under 5s |
What is hepatitis B?
Hepatitis B is a viral disease which affects the liver. It is transmitted through blood, semen and other bodily fluids, mainly through sexual contact with an infected person or by sharing needles. It can also, on rare occasions, be passed from mother to baby during pregnancy. This will be picked up by the routine screening programme in place in Ireland.
Symptoms of hepatitis B generally appear in 90 days and last a few weeks. About half of infected adults and children over the age of five will have symptoms, while many children under the age of five will not. Symptoms include fever, fatigue, loss of appetite, nausea, vomiting, abdominal pain, dark urine, discoloured (clay) bowel movements, joint pain and jaundice (yellowish skin or eyes). For most people, the virus clears up within 6 months and they become immune.
What is the risk of getting hepatitis B in Ireland today?
Given that Hepatitis B is more common in those with multiple sex partners, intravenous drug users sharing needles and sex workers, babies are at an extremely low risk.

What is the risk of death from hepatitis B in Ireland?
There were no deaths from any form of viral hepatitis (A, B, C, D and E) in anyone under the age of 14 in the nineteen years between 1988 and 2006 (before a vaccine).
What vaccine is recommended for hepatitis B (for children) in Ireland?
Infanrix-Hexa (recommended at 2,4,6 and 13 months)
Do vaccines guarantee protection from hepatitis B?
No, you can still get hepatitis B even after vaccination.
Is the hepatitis B vaccine safe?
All vaccines come with risks, some very serious. Below is a summary of potential side effects as listed on the patient information leaflet. You can find full details here.
Risks from each dose of 6 in 1 vaccine Infanrix-Hexa (6-in-1)
| 4 doses recommended at 2,4,6 and 13 months (as per Infanrix Hexa Patient information leaflet Aug 2024) |
| Observed side effects post administration of Infanrix (post marketing) |
|---|
|
| Risk Category | Observed Side Effects |
|---|---|
| Up to 1 in 10,000 (0.01%) | Dermatitis |
| Up to 1 in 1,000 (0.1%) |
|
| Up to 1 in 100 (1%) | Upper respiratory tract infection, tiredness, cough, large swelling at the injected limb |
| Up to 1 in 10 (1% to 10%) |
|
| More than 1 in 10 (10%) |
|
| Other special warnings and precautions |
|---|
|
| Adverse Events on WHO Vigiaccess Reporting System As of August 2024, 73,005 adverse events have been reported for 6-in-1 vaccines. |